Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Genetic Technologies Sponsored ADR Representing 30 Ord Shs GENE

Technology Scientific & Technical Instruments
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a... see more

Recent & Breaking News (NDAQ:GENE)

Genetic Technologies Announces Closing of $8.0 Million Public Offering

GlobeNewswire May 28, 2020

Genetic Technologies Announces Pricing of $8.0 Million Public Offering

GlobeNewswire May 26, 2020

Genetic Technologies Provides Operational Update - Successful Prototype Polygenic Risk Score for COVID-19 Created

GlobeNewswire May 22, 2020

Genetic Technologies - Accelerated development of new COVID-19 Polygenic Risk Test for Risk of Developing Life-Threatening Complications

GlobeNewswire May 20, 2020

Genetic Technologies Announces Closing of $1.44 Million Registered Direct Offering

GlobeNewswire April 23, 2020

Genetic Technologies Announces $1.44 Million Registered Direct Offering

GlobeNewswire April 20, 2020

COVID-19 Testing Capacity at Genetic Technologies Accredited Laboratory

GlobeNewswire April 17, 2020

Genetic Technologies Announces Closing of $1.8 Million Registered Direct Offering

GlobeNewswire April 6, 2020

Genetic Technologies Announces $1.8 Million Registered Direct Offering

GlobeNewswire April 1, 2020

Genetic Technologies Limited Announces Market Update on Sales, Early Test Results and Launch of Consumer Initiated Testing

GlobeNewswire April 1, 2020

Genetic Technologies Limited Announces Receipt of Delisting Notification Letter from Nasdaq

GlobeNewswire March 13, 2020

Genetic Technologies to provide Corporate & Strategic Update at 2020 Biotech Showcase

GlobeNewswire January 13, 2020

20 Medical centers across 8 US states set to offer Breast Cancer Test

GlobeNewswire January 7, 2020

Genetic Technologies to Hold Investor Webinar and Q&A Session on December 18

GlobeNewswire December 17, 2019

Genetype for Breast Cancer commissioned with sales to commence First Quarter 2020

GlobeNewswire December 10, 2019

Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report

GlobeNewswire November 15, 2019

Genetic Technologies Provides Shareholder Update on Recent Achievements and Upcoming Milestones

GlobeNewswire November 5, 2019

Cannabis Stocks Are "No Place to Put Your Money" Reviewers Warn

Livemoney October 23, 2019

Genetic Technologies Announces Offering of Approximately USD 1.2 Million of American Depository Shares

GlobeNewswire May 22, 2019

Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report

GlobeNewswire May 17, 2019